Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. CellaVision AB (publ)
  6. Summary
    CEVI   SE0000683484

CELLAVISION AB (PUBL)

(CEVI)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Stockholm
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
445.4(c) 438.8(c) 436.6(c) 448(c) 445.2(c) Last
8 123 11 379 10 772 14 697 17 027 Volume
-3.05% -1.48% -0.50% +2.61% -0.63% Change
More quotes
Estimated financial data (e)
Sales 2021 566 M 65,2 M 65,2 M
Net income 2021 124 M 14,3 M 14,3 M
Net cash position 2021 82,2 M 9,47 M 9,47 M
P/E ratio 2021 85,6x
Yield 2021 0,41%
Sales 2022 673 M 77,5 M 77,5 M
Net income 2022 161 M 18,5 M 18,5 M
Net cash position 2022 180 M 20,7 M 20,7 M
P/E ratio 2022 66,1x
Yield 2022 0,51%
Capitalization 10 619 M 1 223 M 1 223 M
EV / Sales 2021 18,6x
EV / Sales 2022 15,5x
Nbr of Employees -
Free-Float 64,5%
More Financials
Company
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education.... 
Read more
More about the company
Ratings of CellaVision AB (publ)
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about CELLAVISION AB (PUBL)
07/20CELLAVISION : Increasing activity levels and double-digit growth with maintained..
AQ
07/05CELLAVISION PRESENTS THE INTERIM REP : 00 cest
AQ
04/30CELLAVISION AB (PUBL) : Ex-dividend day for final dividend
FA
04/29CELLAVISION : Bulletin from the annual general meeting of CellaVision AB (publ)
AQ
04/29CellaVision AB Elects Mikael Worning as Chairman of the Board of Directors
CI
04/29CellaVision AB Approves Dividend, Payable on 6 May 2021
CI
04/28CELLAVISION AB : Strong profitability and positive development in Europe
AQ
04/28Sören Mellstig to Leave Cellavision AB as Chairman
CI
04/20CELLAVISION : completes the acquisition of exclusive rights to novel microscopy ..
AQ
04/20CellaVision AB Completes the Acquisition of Exclusive Rights to Novel Microsc..
CI
04/20CELLAVISION AB (OM : CEVI) completed the acquisition of Clearbridge BioPhotonics..
CI
04/15CELLAVISION PRESENTS THE INTERIM REP : 00 cet
AQ
04/08CELLAVISION : Publication of CellaVision AB's Annual and Sustainability Report 2..
AQ
04/07CELLAVISION AB (OM : CEVI) entered into an agreement to acquire Clearbridge BioP..
CI
04/06CELLAVISION : acquires exclusive rights to novel microscopy technology
AQ
More news
News in other languages on CELLAVISION AB (PUBL)
2020AVIS D'ANALYSTES DU JOUR : EasyJet, Givaudan, Lisi, Quadient, Sodexo, Sopra, STM..
More news
Chart CELLAVISION AB (PUBL)
Duration : Period :
CellaVision AB (publ) Technical Analysis Chart | CEVI | SE0000683484 | MarketScreener
Technical analysis trends CELLAVISION AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 445,20 SEK
Average target price 358,33 SEK
Spread / Average Target -19,5%
EPS Revisions
Managers and Directors
Simon Ostergaard President & Chief Executive Officer
Magnus Blixt Chief Financial Officer
Mikael Worning Chairman
Adam Morell Vice President-Engineering
Anna Yvonne Monica Malm Bernsten Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CELLAVISION AB (PUBL)45.02%1 223
SARTORIUS AG96.23%49 859
BIOTAGE AB (PUBL)85.90%1 940
REVENIO GROUP OYJ20.58%1 891
VAREX IMAGING CORPORATION73.38%1 140
ANGLE PLC149.21%384